This inventor holds 1 USPTO granted patent. Top assignee: Aska Pharmaceutical Co., Ltd.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Miwa Yoshida: Innovator in Antiallergic Compounds
Introduction
Miwa Yoshida is a prominent inventor based in Hamura, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiallergic agents. Her innovative work has led to the creation of a heterocyclic compound that serves as an H1 receptor antagonist.
Latest Patents
Miwa Yoshida holds 1 patent for her invention titled "Heterocyclic compound and H1 receptor antagonist." This patent describes a heterocyclic compound that is useful as an antiallergic agent. The compound is represented by a specific formula, which highlights its potential in treating allergic reactions.
Career Highlights
Yoshida is associated with Aska Pharmaceutical Co., Ltd., where she has been instrumental in advancing research and development in the pharmaceutical sector. Her expertise in chemistry and pharmacology has positioned her as a key player in her field.
Collaborations
Throughout her career, Miwa Yoshida has collaborated with notable colleagues, including Takahiro Nishimoto and Kouki Ishitani. These partnerships have fostered innovation and have contributed to the success of her projects.
Conclusion
Miwa Yoshida's contributions to the development of antiallergic compounds exemplify her dedication to improving healthcare through innovation. Her work continues to impact the pharmaceutical industry positively.